Ciro Gallo

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

C. Gridelli, Federica Perrone, Ciro Gallo et al. · JNCI Journal of the National Cancer Institute · 2003 · 795 citations · Full text

Medicine, Oncology, Pharmacology +12

Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials

Massimo Di Maïo, Ciro Gallo, Natasha B. Leighl et al. · Journal of Clinical Oncology · 2015 · 497 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +16

Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study

Paolo Maione, Francesco Perrone, Ciro Gallo et al. · Journal of Clinical Oncology · 2005 · 477 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.

Chiara Carlomagno, Francesco Perrone, Ciro Gallo et al. · Journal of Clinical Oncology · 1996 · 409 citations

Medicine, Oncology, Breast Oncology +13

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

Emanuele Durante‐Mangoni, Giuseppe Signoriello, Roberto Andini et al. · Clinical Infectious Diseases · 2013 · 407 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17